Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus Medical Dialogues Bureau23 Sep 2019 8:46 AM GMTNovo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes Medical Dialogues Bureau21 Sep 2019 4:00 AM GMT"We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...
Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics Medical Dialogues Bureau18 Sep 2019 4:00 AM GMTThis new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
Novo Nordisk gets USFDA for use of Victoza to treat type 2 diabetes in pediatric patients Meghna A Singhania18 Jun 2019 10:37 AM GMTUS The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with...
Glenmark Pharma gets USFDA approval for generic version of VAGIFEM Farhat Nasim25 April 2019 5:20 AM GMTThe approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost Medical Dialogues Bureau30 Dec 2018 3:50 AM GMTZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin Medical Dialogues Bureau17 Oct 2018 9:46 AM GMTUS : Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 5:00 AM GMTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 5:00 AM GMTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs Ruby Khatun Khatun24 Nov 2017 4:00 AM GMTDenmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...
Novo Nordisk partners with Karnataka State Government Employees Association for Diabetes screening and awareness Ruby Khatun Khatun18 Nov 2017 4:18 AM GMTBENGALURU: Novo Nordisk, a global healthcare company with more than 90 years of innovation and leadership in diabetes care organized a diabetes...
FDA approves Novo Nordisk fast-acting insulin Fiasp Ruby Khatun Khatun4 Oct 2017 4:27 AM GMTThe U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
